CL2014000498A1 - Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease. - Google Patents

Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.

Info

Publication number
CL2014000498A1
CL2014000498A1 CL2014000498A CL2014000498A CL2014000498A1 CL 2014000498 A1 CL2014000498 A1 CL 2014000498A1 CL 2014000498 A CL2014000498 A CL 2014000498A CL 2014000498 A CL2014000498 A CL 2014000498A CL 2014000498 A1 CL2014000498 A1 CL 2014000498A1
Authority
CL
Chile
Prior art keywords
class
treating
pharmaceutical composition
heterocyclic compounds
selective inhibitors
Prior art date
Application number
CL2014000498A
Other languages
Spanish (es)
Inventor
Pingda Ren
Alfredo C Castro
Catherine A Evans
Somarajannair Janardanannair
Andre Lescarbeau
Tao Liu
Daniel A Snyder
Martin R Tremblay
Yi Liu
Liansheng Li
Katherina Chan
Original Assignee
Infinity Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Pharmaceuticals Inc filed Critical Infinity Pharmaceuticals Inc
Publication of CL2014000498A1 publication Critical patent/CL2014000498A1/en

Links

CL2014000498A 2011-08-29 2014-02-28 Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease. CL2014000498A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161528585P 2011-08-29 2011-08-29
US201161547343P 2011-10-14 2011-10-14
US201161562278P 2011-11-21 2011-11-21

Publications (1)

Publication Number Publication Date
CL2014000498A1 true CL2014000498A1 (en) 2014-12-19

Family

ID=53403929

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000498A CL2014000498A1 (en) 2011-08-29 2014-02-28 Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.

Country Status (1)

Country Link
CL (1) CL2014000498A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11926616B2 (en) 2018-03-08 2024-03-12 Incyte Corporation Aminopyrazine diol compounds as PI3K-γ inhibitors
US12421197B2 (en) 2018-07-02 2025-09-23 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11926616B2 (en) 2018-03-08 2024-03-12 Incyte Corporation Aminopyrazine diol compounds as PI3K-γ inhibitors
US12365668B2 (en) 2018-03-08 2025-07-22 Incyte Corporation Aminopyrazine diol compounds as PI3K-y inhibitors
US12421197B2 (en) 2018-07-02 2025-09-23 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Similar Documents

Publication Publication Date Title
BR112018073328A2 (en) combination, pharmaceutical composition, kit, cancer treatment method, cell level reduction method, cell level reduction method, activity increasing method, cytotoxicity increasing method
ECSP18040250A (en) COMPOSITIONS AND METHODS TO INHIBIT ARGINASE ACTIVITY
BR112013023175A2 (en) compound, inhibitor, drug, anticancer agent, pharmaceutical composition, method for treating cancer, and use of a compound
SV2016005137A (en) DERIVATIVES OF PIPERIDINIL-INDOL AS INHIBITORS OF COMPLEMENT FACTOR B AND USES OF THE SAME
DK3030323T3 (en) KDM1A INHIBITORS FOR DISEASE TREATMENT
AR091700A1 (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATION
MX369863B (en) CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS.
HUE049442T2 (en) Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
DK3119762T3 (en) BENZIMIDAZOLE DERIVATIVES AS ERBB-TYROSINE CHINASE INHIBITORS FOR THE TREATMENT OF CANCER
CO6761389A2 (en) Nampt and rock inhibitors
CL2015003280A1 (en) Benzimidazole derivatives as bromodomain inhibitors
NI201600071A (en) AUTOTAXIN INHIBITOR COMPOUNDS
DK2968316T3 (en) 2-HYDROXY-1- {4 - [(4-PHENYLPHENYL) CARBONYL] PIPERAZIN-1-YL} ETHAN-1-ON DERIVATIVES AND RELATED COMPOUNDS LIKE FATHERIC ACID SYNTHASE (PHASN) INHIBITORS FOR TREATMENT
CL2014000746A1 (en) Compounds derived from 3-pyrimidin-4-yl-oxazolidin-2-one and their salts, as inhibitors of the mutant idh proteins; pharmaceutical composition that includes them, useful for the treatment of disorders of cell proliferation such as cancer.
SI3021869T1 (en) Procedures for cancer treatment using PD-1 TIGIT antagonists and inhibitors
CL2013001093A1 (en) Tricyclic compounds that inhibit the kinase pi3 (pi3k); pharmaceutical composition that includes them; method to treat cancer; and its use for the treatment of cancer.
EA201591509A1 (en) CDC7 INHIBITORS
IL254779A0 (en) Methods for administering glutaminase inhibitors
CL2014000543A1 (en) Compounds derived from amino substituted imidazopyridazines, kinase inhibitors, mknk2; Preparation method; intermediary compounds and their use; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.
BR112014032053A2 (en) compound, pharmaceutical composition, use of a compound, method for treating cancer and invention
HRP20170928T1 (en) KINURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL PREPARATIONS, AND PROCEDURES FOR THEIR USE
PT3041476T (en) CORTICOSTEROID CONTAINING ORAL DISINTEGRANT TABLET COMPOSITIONS FOR EOSINOPHYLIC ESOPHAGITIS
ECSP16008797A (en) DERIVATIVES OF HETEROBICICLOARIL AS RORC2 INHIBITORS AND METHODS OF USE OF THE SAME
MX2015011386A (en) METHOD TO TREAT PANCREATIC CANCER.
BR112014031899A8 (en) compound, pharmaceutical composition, and method for treating a disorder